Nasdaq · Healthcare
VSEE HEALTH, INC. (VSEE)
As-reported financials and recent SEC filings for VSEE HEALTH, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$14.6M
Net income
$-14.7M
Net margin
-100.6%
Diluted EPS
$-0.73
ROE
-269.8%
P/E (TTM)
—
Market cap
—
Debt / equity
0.1×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $14.6M | $10.4M | $5.8M | — |
| Gross profit | $7.4M | $7.2M | $3.8M | — |
| Operating income | $-9.6M | $-62.2M | $-1.9M | $-3.6M |
| Net income | $-14.7M | $-57.7M | $-3.8M | $-3.2M |
| Diluted EPS | $-0.73 | $-2.83 | $-0.19 | $-0.13 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
424B32026-06-26
View on EDGAR →8-K2026-06-26
View on EDGAR →424B32026-06-11
View on EDGAR →8-K2026-06-11
View on EDGAR →8-K2026-06-11
View on EDGAR →424B32026-06-10
View on EDGAR →8-K2026-06-05
View on EDGAR →42026-06-02
View on EDGAR →Largest Healthcare peers
Go deeper on VSEE
Search VSEE HEALTH, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.